期刊文献+

弓形虫疫苗的研究进展与展望 被引量:3

下载PDF
导出
摘要 弓形虫病是一种重要的机会致病性人兽共患寄生虫病,它给畜牧业造成了巨大的经济损失,同时对公共卫生安全也提出了严峻的挑战。由于它具有较大危害性且至今无理想治疗药物,因此越来越多研究者关注弓形虫疫苗的研究。目前疫苗研究虽已取得了较大进展,但仍然无法完全预防和控制弓形虫病的感染和传播。如何控制牲畜感染弓形虫病带来的经济损失,如何降低人类因食用感染弓形虫病的动物制品而带来的公共卫生安全风险,是预防和控制弓形虫病的重要研究课题。弓形虫病疫苗的研究具有广泛而重要的公共卫生学意义和经济学价值。目前弓形虫疫苗的研究主要有灭活疫苗、弱毒疫苗、基因缺失疫苗、活载体疫苗、DNA疫苗、亚单位疫苗等,本文就目前弓形虫疫苗发展现状及进展探讨如下。
出处 《上海畜牧兽医通讯》 2015年第2期18-21,共4页 Shanghai Journal of Animal Husbandry and Veterinary Medicine
  • 相关文献

参考文献15

  • 1Cutchins E C, Warren J. Immunity patterns in the guinea pig following Toxoplasma infection and vaccina- tion with killed Toxoplasma[J]. Am J Trop Med Hyg, 1956(5): 197-209.
  • 2Saavedra R, Leyva R, Tenorio E P, et al. CpG-contai- ning ODN has a limited role in the protection against Toxoplasma gondii [J]. Parasite Immunol, 2004 (26): 67-73.
  • 3Pfefferkorn E R, Pfefferkorn L C. Toxoplasrna gondii : isolation and preliminary characterization of temperature- sensitive mutants [J]. Exp Parasitol, 1976 (39): 365-371.
  • 4Freyre A, Choromanski L, Fishback J L, et al. Immuni- zation of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii [J]. J Parasitol, 1993(79): 716-719.
  • 5Buxton D. Toxoplasmosis: the first commercial vaccine [J]. Parasitol Today, 1993(9): 335-337.
  • 6Fox B A, Bzik D J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii [J]. Nature, 2002(415): 926-929.
  • 7Mishima M, Xuan X N, Yokoyama N, et al. Recombi- nant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats[J]. Parasitol Res, 2002(88) : 144-149.
  • 8Gazzinelli R T, Caetano B, Fux B, et al. Protective im- mune responses involved in host resistance to Brazilian i- solates of Toxoplasma gondii: implications on vaccine development employing recombinant viral vectors[C]. Proceedings of the IXth International Coccidiosis Confer- ence, 2005, 1 84-90.
  • 9彭高辉,剡海阔,刘苗苗,朱兴全,袁子国.细菌活载体及其在寄生虫疫苗研究上的应用[J].中国畜牧兽医,2010,37(1):88-91. 被引量:2
  • 10Couper K N, Nielsen H V, Petersen E, et al. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-l) protects against adult acquired Toxo- plasma gondii infection but does not prevent materno- foetal transmission[J]. Vaccine, 2003 (21): 2813 -2820.

二级参考文献30

  • 1杨筱凤,陈宏伟,郑瑾,司履生,董小平,王一理.人乳头瘤病毒16L1-减毒志贺氏杆菌为载体疫苗的构建及免疫效应初步鉴定[J].病毒学报,2005,21(3):198-203. 被引量:5
  • 2杜爱芳,王素华,胡松华.减毒沙门氏菌为载体传递鸡球虫DNA疫苗的安全性、稳定性与免疫原性[J].中国兽医学报,2006,26(2):147-150. 被引量:17
  • 3史霖,袁育康,胜利,范桂香.多CTL表位DNA疫苗诱导特异性CTL应答的研究[J].细胞与分子免疫学杂志,2006,22(4):430-432. 被引量:8
  • 4赵军明,荣光,王新华,薄新文.动物寄生虫疫苗的研究进展[J].中国畜牧兽医,2007,34(7):116-119. 被引量:6
  • 5Boland A,Cornelis G R. Interation of Yersinia with host cells[J]. Subcell Biochem, 2000,33 : 343 - 382.
  • 6Grangette C, Muller-Alouf H, Goudercourt D, et al. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum [J]. Infect Immun,2001,69(3) :1547-1553.
  • 7Knapp W,Lysy J,Knapp C,et al. Clinic and diagnosis of enteric infections in man by Yersinia enterocolitica [J]. Infection, 1973,1 (2) :113-125.
  • 8Kochi S K,Killeen K P,Ryan U S. Advances in the development of bacterial vector technology[J]. Expert Rev Vaccines, 2003,2 (1) :31-43.
  • 9Kong D,Belosevic M,Kunimoto D Y. Immunization of BALB/c mice with mIFN gamma secreting Mycobacterium boris BCG provides early protection against Leishmania major infection [J]. Int J Parasitol,1997,27(3) :349-353.
  • 10Konjufca V,Jenkins M,Wang S,et al. Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SOT[J]. Infect Immun,2008,76(12) :5745-5753.

共引文献11

同被引文献39

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部